SONM · NASDAQ
DNA X (SONM) Stock Price & Fundamentals
DNA X (SONM) closed at $987.86 on Oct 9, 2026, up 0.09% from the previous close of $987.00.
Share price, past year
1Y +33.09%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $987.86 |
| Sep 30, 2026 | $971.53 |
| Aug 31, 2026 | $944.03 |
| Jul 31, 2026 | $903.15 |
| Jun 30, 2026 | $887.91 |
| May 29, 2026 | $862.29 |
| Apr 30, 2026 | $833.91 |
| Mar 31, 2026 | $811.83 |
| Feb 27, 2026 | $823.23 |
| Jan 30, 2026 | $774.42 |
| Dec 31, 2025 | $754.88 |
| Nov 28, 2025 | $755.55 |
| Oct 31, 2025 | $745.87 |
Key statistics
- Market cap
- $1.47B
- P/E (TTM)
- —
- EPS (TTM)
- −$11.75
- Revenue (TTM)
- —
- Net income (TTM)
- −$8.55M
- Shares outstanding
- 1.5M
- Dividend yield
- —
- 52-week range
- $738.12 – $992.41
DNA X's market cap is $1.47B, based on a share price of $987.86 and 1.5M shares outstanding as of Jun 30, 2026.
Financials
DNA X reported revenue of $58.30M for fiscal 2024, down 37.74% from fiscal 2023.
DNA X reported a net loss of $20.66M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $58.30M | −37.7% | −$33.65M | −57.7% | −$128.37 | −$8.70M |
| FY2023ended Dec 31, 2023 | $93.63M | +34.1% | −$90.00K | −0.1% | −$0.02 | −$4.09M |
| FY2022ended Dec 31, 2022 | $69.83M | +28.0% | −$14.09M | −20.2% | −$0.49 | −$12.37M |
| FY2021ended Dec 31, 2021 | $54.57M | −14.7% | −$38.63M | −70.8% | −$4.08 | −$38.52M |
| FY2020ended Dec 31, 2020 | $63.99M | −45.0% | −$29.93M | −46.8% | −$6.48 | −$10.57M |
| FY2019ended Dec 31, 2019 | $116.25M | −14.3% | −$25.83M | −22.2% | −$1.39 | −$34.52M |
| FY2018ended Dec 31, 2018 | $135.67M | — | $1.28M | 0.9% | −$2.57 | $3.07M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | $16.21M | −$4.75M | −$4.83 |
| Q2 FY2025ended Jun 30, 2025 | $11.19M | −$7.48M | −$14.15 |
| Q1 FY2025ended Mar 31, 2025 | $16.72M | $458.00K | $1.41 |
| Q4 FY2024ended Dec 31, 2024 | $14.98M | −$21.61M | −$116.99 |
| Q3 FY2024ended Sep 30, 2024 | $15.02M | −$2.51M | −$9.32 |
| Q2 FY2024ended Jun 30, 2024 | $11.52M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $16.78M | — | — |
| Q4 FY2023ended Dec 31, 2023 | $13.43M | — | — |
Company profile
- Name
- DNA X, Inc.
- Ticker
- SONM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Telephone & Telegraph Apparatus
- Headquarters
- 4445 Eastgate Mall, Suite 200, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001178697
Recent SEC filings
- Aug 31, 2026
- Aug 27, 2026
- Aug 19, 2026
- Jul 2, 2026
- Jun 4, 2026
- May 27, 2026
- May 20, 2026
- May 20, 2026
Frequently asked questions
What is DNA X's stock price?
DNA X (SONM) closed at $987.86 on Oct 9, 2026, up 0.09% from the previous close of $987.00.
What is DNA X's market cap?
DNA X's market cap is $1.47B, based on a share price of $987.86 and 1.5M shares outstanding as of Jun 30, 2026.
How much revenue does DNA X make?
DNA X reported revenue of $58.30M for fiscal 2024, down 37.74% from fiscal 2023.
Does DNA X pay a dividend?
DNA X's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DNA X, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures